Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
The American Surgeon|February 17, 2017
Independent Preoperative Predictors of Prolonged Length of Stay after Laparoscopic Appendectomy in Patients Over 30 Years of Age: Experience from a Single InstitutionEric S Wise, Stephen P Gadomski, Annette M Ilg, et al.
Molecular Vision|July 9, 2003
Genetic, ophthalmic, morphometric and histopathological analysis of the Retinopathy Globe Enlarged (rge) chickenChris F Inglehearn, David R Morrice, Douglas H Lester, et al.
Frontiers in Genetics|December 12, 2018
Dissecting the Genomic Architecture of Resistance to Eimeria maxima Parasitism in the ChickenKay Boulton, Matthew J Nolan, Zhiguang Wu, et al.
JCI Insight|October 25, 2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell functionCate Speake, Tania Habib, Katharina Lambert, et al.
Scientific Reports|January 13, 2021
Quantitative trait loci and transcriptome signatures associated with avian heritable resistance to CampylobacterAndroniki Psifidi, Andreas Kranis, Lisa M Rothwell, et al.
The Lancet. Oncology|June 10, 2022
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trialRobert J Motzer, Thomas Powles, Mauricio Burotto, et al.
Investigative Ophthalmology & Visual Science|August 25, 2011
Mpdz null allele in an avian model of retinal degeneration and mutations in human leber congenital amaurosis and retinitis pigmentosaManir Ali, Paul M Hocking, Martin McKibbin, et al.
NPJ Biofilms and Microbiomes|November 20, 2025
Chemical inhibition of MrkH-dependent activation of type 3 fimbriae synthesis and biofilm formation by Klebsiella pneumoniaeJonathan J Wilksch, Jason W H Tan, Tracy L Nero, et al.
Nature Communications|November 3, 2024
Distribution and diversity of classical deacylases in bacteriaLeonie G Graf, Carlos Moreno-Yruela, Chuan Qin, et al.
Cancer|July 4, 2025
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, et al.
Pageof 33